PHILADELPHIA, May 22, 2024 (GLOBE NEWSWIRE) -- Trial Equity and Miller Tanner Associates (MTA) are excited to announce a groundbreaking partnership aimed at expanding education and participation across diverse patient groups, in a strategic move to address the crucial gap in clinical trial diversity.

费城，2024年5月22日（环球通讯社）--Trial Equity和Miller Tanner Associates（MTA）很高兴宣布一项开创性的合作伙伴关系，旨在扩大不同患者群体的教育和参与，这是一项战略性举措，以解决临床试验多样性的关键差距。

This collaboration will co-market Trial Equity’s innovative Clinical Trial Diversity Training to pharmaceutical sponsors, CROs, and site networks, leveraging MTA's extensive global reach and expertise in event management within the healthcare sector. Miller Tanner Associates, a Women’s Business Enterprise National Council (WBENC)-certified leader in life sciences and corporate event planning, brings its sterling reputation and logistical prowess to this partnership.

此次合作将共同向制药赞助商、首席风险官和网站网络推广Trial Equity的创新临床试验多样性培训，利用MTA在医疗保健领域的广泛全球影响力和事件管理专业知识。米勒·坦纳协会（Miller Tanner Associates）是女性商业企业全国委员会（WBENC）认证的生命科学和企业活动规划领导者，为这一合作关系带来了卓越的声誉和物流能力。

Known for its personalized expertise and tailored solutions in managing Face-to-Face, Virtual, and Hybrid meetings, MTA will now also promote Trial Equity's eLearning course through its Event Content Management (ECM) platform, VALTs (Virtual Assessment, Learning & Training source). MTA will further empower healthcare professionals (HCPs) to implement diversity in clinical trials by offering Trial Equity’s vital diversity workshops at Investigator Meetings.

MTA以其在管理面对面、虚拟和混合会议方面的个性化专业知识和量身定制的解决方案而闻名，现在还将通过其活动内容管理（ECM）平台VALTs（虚拟评估、学习和培训来源）推广Trial Equity的在线学习课程。MTA将通过在研究者会议上提供试验公平的重要多样性研讨会，进一步授权医疗保健专业人员（HCP）在临床试验中实施多样性。

'Partnering with Miller Tanner Associates was a strategic choice, driven by their deep expertise in life sciences and masterful event planning,” shared Dr. Otis Johnson, Co-founder, Trial Equity. “Their innovative VALTs platform and extensive global experience are key to effectively delivering our Clinical Trial Diversity Training worldwide.

Trial Equity联合创始人奥蒂斯·约翰逊（Otis Johnson）博士分享道：“与米勒·坦纳联合公司（Miller Tanner Associates）合作是一项战略选择，这得益于他们在生命科学领域的深厚专业知识和精湛的活动策划。”。“他们创新的VALTs平台和广泛的全球经验是在全球范围内有效提供临床试验多样性培训的关键。

This partnership marks a critical step toward ensuring future medical breakthroughs are effective and accessible to everyone, truly reflecting the diverse communities we aim to serve.” Both the eLearning course and in-p.

这种伙伴关系标志着朝着确保未来医学突破有效且人人都能获得的关键一步，真正反映了我们旨在服务的多样化社区。”在线学习课程和in-p。